CD5 and acute lymphoblastic leukemia: Moreover, these findings provide new insights into the mechanisms of immune dysfunction in hematologic malignancies such as T-ALL and chronic lymphocytic leukemia, where immune dysregulation, including altered CD5 expression, is a common feature.